On Monday, X4 Pharmaceuticals Inc (NASDAQ: XFOR) opened higher 6.99% from the last session, before settling in for the closing price of $1.43. Price fluctuations for XFOR have ranged from $1.38 to $26.96 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 47.41%. Company’s average yearly earnings per share was noted -55.05% at the time writing. With a float of $3.84 million, this company’s outstanding shares have now reached $5.79 million.
The extent of productivity of a business whose workforce counts for 143 workers is very important to gauge. In terms of profitability, gross margin is 82.42%, operating margin of -27.28%, and the pretax margin is 47.58%.
X4 Pharmaceuticals Inc (XFOR) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of X4 Pharmaceuticals Inc is 33.66%, while institutional ownership is 29.13%. The most recent insider transaction that took place on May 16 ’25, was worth 2,561. In this transaction Chief Commercial Officer of this company bought 1,032 shares at a rate of $2.48, taking the stock ownership to the 25,337 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Chief Commercial Officer bought 13,404 for $0.34, making the entire transaction worth $4,598. This insider now owns 129,173 shares in total.
X4 Pharmaceuticals Inc (XFOR) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -55.05% per share during the next fiscal year.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
Check out the current performance indicators for X4 Pharmaceuticals Inc (XFOR). In the past quarter, the stock posted a quick ratio of 3.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.24, a number that is poised to hit -3.94 in the next quarter and is forecasted to reach -8.77 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
The latest stats from [X4 Pharmaceuticals Inc, XFOR] show that its last 5-days average volume of 1.56 million was superior to 0.25 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 21.83%.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 1.23%, which indicates a significant decrease from 20.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1569 in the past 14 days, which was lower than the 0.5601 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.6708, while its 200-day Moving Average is $10.6149.
